Bayer AG Stock
There is an upward development for Bayer AG compared to yesterday, with an increase of €0.57 (1.050%).
Currently there is a rather positive sentiment for Bayer AG with 39 Buy predictions and 5 Sell predictions.
As a result the target price of €73.00 shows a positive potential of 40.845% compared to the current price of €51.83 for Bayer AG.
For the coming years our community has positive and negative things to say abot the Bayer AG stock. Criterium "Brand" gathered the most positive votes but regarding "Debt" there were negative voices in the community.
Currently there is a rather positive sentiment for Bayer AG with 39 Buy predictions and 5 Sell predictions.
As a result the target price of €73.00 shows a positive potential of 40.845% compared to the current price of €51.83 for Bayer AG.
For the coming years our community has positive and negative things to say abot the Bayer AG stock. Criterium "Brand" gathered the most positive votes but regarding "Debt" there were negative voices in the community.
Pros and Cons of Bayer AG in the next few years
Pros
6
Well known brand
6
Top 10 in its market
6
Could be worthwhile Investment >10% per year
Cons
6
Increased challenges to pay loans and raise capital
4
Risky balance sheet
4
Sustainability is little important
Performance of Bayer AG vs. its peers
Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Bayer AG | 1.050% | 2.471% | -7.694% | -19.306% | 6.932% | -46.567% | -47.354% |
Merck KGaA | -1.690% | -3.262% | -8.034% | 18.636% | -6.519% | 60.319% | 62.516% |
Zoetis Inc. A | 1.160% | -5.080% | -7.550% | 0.775% | -8.189% | 85.545% | 230.628% |
Biogen Inc. | 3.130% | 0.509% | 3.180% | -19.239% | 14.201% | -0.695% | -6.934% |
Comments
Buy Bayer AG
Buy Bayer AG
Sell Bayer AG
Other discussions about Bayer AG Stock
Trading Bayer AG
Trading Bayer AG
News
DGAP-Adhoc: Bayer Aktiengesellschaft: Bayer to accelerate transformation to address challenging market environment and enable additional growth investments
DGAP-Adhoc: Bayer Aktiengesellschaft: Bayer to accelerate transformation to address challenging market environment and enable additional growth investments